Top VA pharmaceutical preparation manufacturing contractors (NAICS 325412)
- Latest 12 months
- $11.0B
- Net obligations · Down $755.6M vs. $11.8B preceding
- Prime contractors
- 130
- With positive obligations in the latest 12 months
Research the VA federal contracting market for pharmaceutical preparation manufacturing under NAICS 325412. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.
Contract obligation trends for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs
Federal records show $50.5B in net obligations across 6,591 awards in Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Oct 4, 2026. This market accounts for 14.7% of $344.1B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 6.4% from $11.8B to $11.0B. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY27 is year-to-date through Oct 4, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $8.3B | 2,193 | Complete |
| FY2023 | $9.4B | 2,088 | Complete |
| FY2024 | $8.8B | 2,417 | Complete |
| FY2025 | $11.7B | 2,089 | Complete |
| FY2026 | $12.3B | 2,035 | Complete |
Market at a glance
All reported prime contract awards- All-period net obligations
- $50.5B
- 6,591 awards · 359 prime contractors
- Latest 12-month movement
- −6.4%
- $11.0B vs. $11.8B
- Leading eight prime share
- 99.5%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 14.7% of $344.1B in agency-wide net obligations.
- Set-aside share when reported
- 33.3% of 2,534 awards with reported set-aside status.
- Set-aside reporting
- 845 set aside · 1,689 no set-aside · 4,057 not reported
What changed in the last 12 months?
Oct 5, 2025–Oct 4, 2026, compared with Oct 5, 2024–Oct 4, 2025.
Market structure
Award activity
MCKESSON CORPORATION received an unusually large obligation action
Competitive shifts
MCKESSON CORPORATION had the largest decline in reported obligations
EXELAN PHARMACEUTICALS INC climbed the most in the contractor rankings
Buyer demand
Reported obligations through VHA CHIEF LOGISTICS OFFICE (36C240) decreased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Oct 4, 2026.
97.9% of positive obligations were attributed to VHA CHIEF LOGISTICS OFFICE (36C240). That represents $10.8B, down $768.6M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- VHA CHIEF LOGISTICS OFFICE (36C240)97.9% · $10.8B · down $768.6M
- 691-VA GREATER LA HLTHCR SYS(00691)0.090% · $9.8M · up $2.2M
- 541-BRECKSVILLE (00541)0.090% · $9.6M · up $5.1M
- 242-NETWORK CONTRACT OFFICE 02 (36C242)0.090% · $9.5M · up $4.8M
- 549-DALLAS (00549)0.070% · $7.6M · up $347K
- All other reported offices1.8% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
VHA CHIEF LOGISTICS OFFICE (36C240)
#1Rank unchangedLatest 12 months
$10.8B
97.9% of positive obligations
Versus preceding 12 months
−$768.6M
1 active prime contractor · 9 awards
View office comparison and evidence
Reported obligations decreased 6.6% from $11.6B to $10.8B. The office’s share of positive obligations moved from 98.2% to 97.9%, a change of −0.3 percentage points.
The latest period contains 9 actions across 9 awards. The preceding period contained 1 active prime contractor and 12 awards.
Leading award-level changes
- MCKESSON CORPORATION · PIID 36C24026K1002+$1.4B: $0 → $1.4B
- MCKESSON CORPORATION · PIID 36C24026K1008+$1.4B: $0 → $1.4B
Reported funding office
691-VA GREATER LA HLTHCR SYS(00691)
#2Up 3 from #5Latest 12 months
$9.8M
0.090% of positive obligations
Versus preceding 12 months
+$2.2M
15 active prime contractors · 23 awards
View office comparison and evidence
Reported obligations increased 29.2% from $7.6M to $9.8M. The office’s share of positive obligations moved from 0.060% to 0.090%, a change of 0.0 percentage points.
The latest period contains 29 actions across 23 awards and 3 newly active prime contractors. The preceding period contained 15 active prime contractors and 22 awards.
Reported funding office
541-BRECKSVILLE (00541)
#3Up 9 from #12Latest 12 months
$9.6M
0.090% of positive obligations
Versus preceding 12 months
+$5.1M
16 active prime contractors · 28 awards
View office comparison and evidence
Reported obligations increased 114.7% from $4.5M to $9.6M. The office’s share of positive obligations moved from 0.040% to 0.090%, a change of +0.1 percentage points.
The latest period contains 39 actions across 28 awards and 7 newly active prime contractors. The preceding period contained 11 active prime contractors and 16 awards.
Leading award-level changes
- EXELAN PHARMACEUTICALS INC · PIID 36C25026N0292+$2.6M: $0 → $2.6M
- PROGENICS PHARMACEUTICALS INC · PIID 36C25026N0354+$2.4M: $0 → $2.4M
Reported funding office
242-NETWORK CONTRACT OFFICE 02 (36C242)
#4Up 7 from #11Latest 12 months
$9.5M
0.090% of positive obligations
Versus preceding 12 months
+$4.8M
8 active prime contractors · 13 awards
View office comparison and evidence
Reported obligations increased 103.7% from $4.7M to $9.5M. The office’s share of positive obligations moved from 0.040% to 0.090%, a change of +0.1 percentage points.
The latest period contains 20 actions across 13 awards and 3 newly active prime contractors. The preceding period contained 9 active prime contractors and 18 awards.
Reported funding office
549-DALLAS (00549)
#5Up 1 from #6Latest 12 months
$7.6M
0.070% of positive obligations
Versus preceding 12 months
+$347K
11 active prime contractors · 25 awards
View office comparison and evidence
Reported obligations increased 4.8% from $7.2M to $7.6M. The office’s share of positive obligations moved from 0.060% to 0.070%, a change of 0.0 percentage points.
The latest period contains 38 actions across 25 awards and 1 newly active prime contractor. The preceding period contained 12 active prime contractors and 22 awards.
Reported funding office
578-HINES(00578)(36C578)
#6Up 12 from #18Latest 12 months
$7.0M
0.060% of positive obligations
Versus preceding 12 months
+$3.0M
14 active prime contractors · 21 awards
View office comparison and evidence
Reported obligations increased 74.2% from $4.0M to $7.0M. The office’s share of positive obligations moved from 0.030% to 0.060%, a change of 0.0 percentage points.
The latest period contains 31 actions across 21 awards and 5 newly active prime contractors. The preceding period contained 11 active prime contractors and 25 awards.
Reported funding office
NATIONAL CMOP OFFICE (36C770)
#7Down 5 from #2Latest 12 months
$6.5M
0.060% of positive obligations
Versus preceding 12 months
−$10.8M
12 active prime contractors · 16 awards
View office comparison and evidence
Reported obligations decreased 62.5% from $17.3M to $6.5M. The office’s share of positive obligations moved from 0.15% to 0.060%, a change of −0.1 percentage points.
The latest period contains 21 actions across 16 awards and 3 newly active prime contractors. The preceding period contained 23 active prime contractors and 65 awards.
Reported funding office
626-NASHVILLE (00626)
#8Down 5 from #3Latest 12 months
$6.5M
0.060% of positive obligations
Versus preceding 12 months
−$3.0M
11 active prime contractors · 33 awards
View office comparison and evidence
Reported obligations decreased 32.0% from $9.5M to $6.5M. The office’s share of positive obligations moved from 0.080% to 0.060%, a change of 0.0 percentage points.
The latest period contains 37 actions across 33 awards and 4 newly active prime contractors. The preceding period contained 12 active prime contractors and 53 awards.
Reported funding office
VETERANS HEALTH ADMINISTRATION
#9Up 30 from #39Latest 12 months
$6.3M
0.060% of positive obligations
Versus preceding 12 months
+$4.5M
6 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations increased 248.9% from $1.8M to $6.3M. The office’s share of positive obligations moved from 0.020% to 0.060%, a change of 0.0 percentage points.
The latest period contains 8 actions across 7 awards and 4 newly active prime contractors. The preceding period contained 4 active prime contractors and 8 awards.
Reported funding office
521-BIRMINGHAM(00521)(36C521)
#10Up 49 from #59Latest 12 months
$6.0M
0.050% of positive obligations
Versus preceding 12 months
+$4.9M
5 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations increased 462.3% from $1.1M to $6.0M. The office’s share of positive obligations moved from 0.010% to 0.050%, a change of 0.0 percentage points.
The latest period contains 15 actions across 5 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 5 awards.
Reported funding office
672-SAN JUAN (00672)(36C672)
#16New to the positive-obligation rankingLatest 12 months
$4.7M
0.040% of positive obligations
Versus preceding 12 months
+$5.0M
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations moved from $245K in net deobligations to $4.7M in net obligations. The office’s share of positive obligations moved from 0% to 0.040%, a change of 0.0 percentage points.
The latest period contains 3 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 2 awards.
Reported funding office
VA CMOP TUCSON (00762)
#64Down 60 from #4Latest 12 months
$1.0M
0.010% of positive obligations
Versus preceding 12 months
−$7.1M
9 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations decreased 87.0% from $8.1M to $1.0M. The office’s share of positive obligations moved from 0.070% to 0.010%, a change of −0.1 percentage points.
The latest period contains 15 actions across 14 awards and 3 newly active prime contractors. The preceding period contained 9 active prime contractors and 20 awards.
Reported funding office
NAC PHARMACEUTICALS (36E797)
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$6.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $6.8M to $0. The office’s share of positive obligations moved from 0.060% to 0%, a change of −0.1 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 34 awards.
Reported funding office
580-HOUSTON(00580)
No positive-obligation rankLatest 12 months
−$2.1M
0% of positive obligations
Versus preceding 12 months
−$9.1M
8 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations moved from $6.9M in net obligations to $2.1M in net deobligations. The office’s share of positive obligations moved from 0.060% to 0%, a change of −0.1 percentage points.
The latest period contains 22 actions across 14 awards. The preceding period contained 12 active prime contractors and 15 awards.
Contract types, competition, and procurement methods
From Oct 5, 2025 through Oct 4, 2026, 968 awards had positive obligations totaling $11.1B. Negotiated Proposal/Quote was the leading reported procedure, accounting for 86.8% of positive obligations. Awards with a reported parent IDV accounted for 99.5%. Reported awards used contract vehicles such as VA FSS Schedule 65IB.
- Leading award type
- 99.2%
- Delivery Order
- Leading reported procedure
- 86.8%
- Negotiated Proposal/Quote
- Reported parent IDV
- 99.5%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 723 of 968 awards reported offers
Observed contract vehicles
Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.
- VA FSS Schedule 65IB
$7.7M
0.070% of positive obligations · 55 matched awards
Buying method changes
Compared with Oct 5, 2024–Oct 4, 2025. Based on 968 current awards and 1,242 preceding awards with positive net obligations.
- Negotiated Proposal/Quote obligation share
- 86.8%
- Down from 98.0% in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325412 peer median, parent-IDV obligation share is 17.4 percentage points higher, reported full-and-open obligation share is 54.4 percentage points higher, delivery-order obligation share is 20.3 percentage points higher, and median positive award obligations are 342.9% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 99.5% | 82.1% | +17.4 pts |
| Reported full-and-open obligation share | 88.0% | 33.7% | +54.4 pts |
| Delivery-order obligation share | 99.2% | 78.9% | +20.3 pts |
| Median positive award obligations | $50K | $11K | +342.9% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 592 | $11.0B | 99.2% |
| Purchase Order(B) | 273 | $46.6M | 0.42% |
| BPA Call(A) | 90 | $35.7M | 0.32% |
| Definitive Contract(D) | 13 | $3.7M | 0.030% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 173 | $10.9B | 97.9% |
| FSS(C) | 419 | $145.5M | 1.3% |
| BPA(E) | 90 | $35.7M | 0.32% |
| Not reported | 286 | $50.3M | 0.45% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 261 | $10.9B | 98.2% |
| Multiple Award(M) | 421 | $145.7M | 1.3% |
| Not reported | 286 | $50.3M | 0.45% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 55 | $9.6B | 86.8% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 7 | $1.2B | 10.8% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 418 | $137.5M | 1.2% |
| Simplified Acquisition(SP1) | 239 | $57.9M | 0.52% |
| Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY) | 75 | $38.5M | 0.35% |
| Only One Source(SSS) | 91 | $12.2M | 0.11% |
| Other reported values | 83 | $16.2M | 0.15% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full and Open Competition(A) | 465 | $9.8B | 88.0% |
| A(FULL AND OPEN COMPETITION) | 80 | $1.2B | 11.2% |
| Competed Under SAP(F) | 157 | $50.6M | 0.46% |
| Not Competed(C) | 90 | $12.0M | 0.11% |
| F(COMPETED UNDER SAP) | 35 | $7.9M | 0.070% |
| Not Competed Under SAP(G) | 82 | $7.3M | 0.070% |
| Other reported values | 59 | $11.8M | 0.11% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 383 | $100.6M | 0.91% |
| Fair Opportunity Given(FAIR) | 83 | $68.0M | 0.61% |
| Competitive Set Aside(CSA) | 4 | $4.4M | 0.040% |
| Urgency(URG) | 17 | $2.7M | 0.020% |
| Other Statutory Authority(OSA) | 6 | $332K | 0% |
| Not reported | 475 | $10.9B | 98.4% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 111 | $16.4M | 0.15% |
| SAP Non-Competition (FAR 13)(SP2) | 56 | $7.5M | 0.070% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 38 | $2.4M | 0.020% |
| Urgency (FAR 6.302-2)(URG) | 14 | $1.6M | 0.010% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 1 | $37K | 0% |
| Less Than or Equal to the Micro-Purchase Threshold(MPT) | 2 | $5K | 0% |
| Not reported | 746 | $11.1B | 99.7% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 802 | $9.8B | 88.7% |
| J(FIRM FIXED PRICE) | 165 | $1.3B | 11.3% |
| Fixed Price with Economic Price Adjustment(K) | 1 | $629K | 0.010% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs and Biologicals(6505) | 871 | $11.1B | 99.8% |
| Pharmacy Services(Q517) | 23 | $7.8M | 0.070% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 20 | $5.0M | 0.040% |
| Medical- Nuclear Medicine(Q527) | 13 | $4.8M | 0.040% |
| Chemical and Pharmaceutical Products Manufacturing Machinery(3650) | 9 | $1.6M | 0.010% |
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 6 | $1.2M | 0.010% |
| Other reported values | 26 | $4.1M | 0.037% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of Veterans Affairs(3600) | 968 | $11.1B | 100.0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Vha Chief Logistics Office (36c240)(36C240) | 9 | $10.8B | 97.4% |
| 262-Network Contract Office 22 (36c262)(36C262) | 68 | $39.0M | 0.35% |
| 246-Network Contracting Office 6 (36c246)(36C246) | 26 | $29.6M | 0.27% |
| 252-Network Contract Office 12 (36c252)(36C252) | 40 | $24.3M | 0.22% |
| 250-Network Contract Office 10 (36c250)(36C250) | 43 | $19.9M | 0.18% |
| 257-Network Contract Office 17 (36c257)(36C257) | 32 | $17.2M | 0.15% |
| Other reported values | 750 | $154.4M | 1.4% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36W79720D0001(3600) | 10 | $10.8B | 97.4% |
| 36F79720D0227(3600) | 43 | $64.5M | 0.58% |
| 36F79720D0180(3600) | 31 | $30.0M | 0.27% |
| 36F79725D0093(3600) | 21 | $18.2M | 0.16% |
| 36C26226A0006(3600) | 8 | $17.5M | 0.16% |
| 36F79724D0101(3600) | 24 | $7.2M | 0.060% |
| 36F79719D0170(3600) | 14 | $4.9M | 0.040% |
| 36F79720D0182(3600) | 22 | $2.7M | 0.020% |
| Other reported values | 509 | $88.9M | 0.80% |
| Not reported | 286 | $50.3M | 0.45% |
Exact vehicle-match evidence
- VA FSS Schedule 65IB
55 awards · 11 matched parent PIIDs
Evidence: 36F79719D0169, 36F79719D0170, 36F79722D0165, 36F79723D0158, 36F79724D0190, …
$7.7M · 0.070%
Reported award data linked 55 awards to a specific catalog vehicle.
Offers, award size, and timing
- Median reported offers
- 1 median
- 723 reported · 245 not reported
- Positive award obligations
- $50K median
- $19K–$291K middle 50%
- Reported performance period
- 102 days (~3 months) median
- 967 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 4, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 130prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 97.8%of positive obligations in the last 12 months
- Leading four prime contractors
- 99.2%of positive obligations in the last 12 months
- Leading eight prime contractors
- 99.5%of positive obligations in the last 12 months
Based on $11.1B in positive obligations during the 12 months ending Oct 4, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 5, 2024–Oct 4, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$10.8B
97.8%
Dollar movement
−$769.3M
vs. prior 12 months
Last 12mo awards
12 awards
12 actions
Historical and award details for MCKESSON CORPORATION
- Obligations: prior → latest
- $11.6B → $10.8B
- −6.6%
- Share: prior → latest
- 98.2% → 97.8%
- −0.4 percentage points
- All-period obligations
- $49.4B
- 97.8% of all-period positive obligations · 164 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 38 Not reported 10 12 Reported small business 0 0 All-period set-aside types
- 1 · Total small business
- #2
Last 12mo obligations
$95.7M
0.86%
Dollar movement
+$94.1M
vs. prior 12 months
Last 12mo awards
63 awards
110 actions
Historical and award details for EXELAN PHARMACEUTICALS INC
- Obligations: prior → latest
- $1.5M → $95.7M
- +6256.7%
- Share: prior → latest
- 0.010% → 0.86%
- +0.8 percentage points
- All-period obligations
- $100.6M
- 0.20% of all-period positive obligations · 98 awards
- Recorded activity
- Since Jun 21, 2022
- through Sep 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 7 0 Not reported 56 18 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$29.2M
0.26%
Dollar movement
−$7.2M
vs. prior 12 months
Last 12mo awards
69 awards
101 actions
Historical and award details for PROGENICS PHARMACEUTICALS INC
- Obligations: prior → latest
- $36.4M → $29.2M
- −19.8%
- Share: prior → latest
- 0.31% → 0.26%
- −0.1 percentage points
- All-period obligations
- $134.6M
- 0.27% of all-period positive obligations · 163 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 2 Reported no set-aside 0 3 Not reported 67 73 Reported small business 69 78 All-period set-aside types
- 7 · Total small business
- #4
Last 12mo obligations
$28.0M
0.25%
Dollar movement
+$12.7M
vs. prior 12 months
Last 12mo awards
35 awards
47 actions
Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
- Obligations: prior → latest
- $15.2M → $28.0M
- +83.8%
- Share: prior → latest
- 0.13% → 0.25%
- +0.1 percentage points
- All-period obligations
- $43.2M
- 0.090% of all-period positive obligations · 51 awards
- Recorded activity
- Since Oct 22, 2021
- through Sep 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 35 23 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$8.9M
0.080%
Dollar movement
−$16.2M
vs. prior 12 months
Last 12mo awards
111 awards
149 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $25.0M → $8.9M
- −64.6%
- Share: prior → latest
- 0.21% → 0.080%
- −0.1 percentage points
- All-period obligations
- $106.4M
- 0.21% of all-period positive obligations · 394 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 27 50 Not reported 84 90 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$8.8M
0.080%
Dollar movement
+$1.2M
vs. prior 12 months
Last 12mo awards
71 awards
81 actions
Historical and award details for BRISTOL-MYERS SQUIBB COMPANY
- Obligations: prior → latest
- $7.6M → $8.8M
- +15.5%
- Share: prior → latest
- 0.060% → 0.080%
- 0.0 percentage points
- All-period obligations
- $21.2M
- 0.040% of all-period positive obligations · 111 awards
- Recorded activity
- Since Mar 22, 2022
- through Sep 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 71 28 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$8.2M
0.070%
Dollar movement
+$3.5M
vs. prior 12 months
Last 12mo awards
31 awards
46 actions
Historical and award details for RLS (USA) INC.
- Obligations: prior → latest
- $4.7M → $8.2M
- +73.5%
- Share: prior → latest
- 0.040% → 0.070%
- 0.0 percentage points
- All-period obligations
- $22.0M
- 0.040% of all-period positive obligations · 61 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 1, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 4 4 Reported no set-aside 8 9 Not reported 19 15 Reported small business 24 24 All-period set-aside types
- 8 · Total small business
- #8
Last 12mo obligations
$6.4M
0.060%
Dollar movement
+$3.3M
vs. prior 12 months
Last 12mo awards
34 awards
54 actions
Historical and award details for PETNET SOLUTIONS, INC.
- Obligations: prior → latest
- $3.0M → $6.4M
- +110.3%
- Share: prior → latest
- 0.030% → 0.060%
- 0.0 percentage points
- All-period obligations
- $15.4M
- 0.030% of all-period positive obligations · 99 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 9 Not reported 21 24 Reported small business 5 10 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$4.2M
0.040%
Dollar movement
+$2.9M
vs. prior 12 months
Last 12mo awards
6 awards
11 actions
Historical and award details for NUCLEAR DIAGNOSTIC PRODUCTS, INC
- Obligations: prior → latest
- $1.2M → $4.2M
- +235.8%
- Share: prior → latest
- 0.010% → 0.040%
- 0.0 percentage points
- All-period obligations
- $8.4M
- 0.020% of all-period positive obligations · 24 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 1 0 Reported no set-aside 2 3 Not reported 3 9 Reported small business 6 12 All-period set-aside types
- 2 · Total small business
- #10
Last 12mo obligations
$3.3M
0.030%
Dollar movement
−$8.7M
vs. prior 12 months
Last 12mo awards
32 awards
61 actions
Historical and award details for SOFIE CO.
- Obligations: prior → latest
- $12.0M → $3.3M
- −72.4%
- Share: prior → latest
- 0.10% → 0.030%
- −0.1 percentage points
- All-period obligations
- $45.1M
- 0.090% of all-period positive obligations · 78 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 3 Reported no set-aside 13 15 Not reported 17 12 Reported small business 30 28 All-period set-aside types
- 8 · Total small business
- #11
Last 12mo obligations
$3.0M
0.030%
Dollar movement
−$1.5M
vs. prior 12 months
Last 12mo awards
8 awards
10 actions
Historical and award details for PHARMACY BUYING ASSOCIATION, INC.
- Obligations: prior → latest
- $4.5M → $3.0M
- −33.2%
- Share: prior → latest
- 0.040% → 0.030%
- 0.0 percentage points
- All-period obligations
- $30.0M
- 0.060% of all-period positive obligations · 212 awards
- Recorded activity
- Since Oct 29, 2021
- through Jul 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 6 22 Reported no set-aside 2 9 Not reported 0 0 Reported small business 8 31 All-period set-aside types
- 131 · Total small business
- #12
Last 12mo obligations
$3.0M
0.030%
Dollar movement
−$274K
vs. prior 12 months
Last 12mo awards
56 awards
66 actions
Historical and award details for MEDI-PHYSICS, INC.
- Obligations: prior → latest
- $3.3M → $3.0M
- −8.4%
- Share: prior → latest
- 0.030% → 0.030%
- 0.0 percentage points
- All-period obligations
- $16.2M
- 0.030% of all-period positive obligations · 150 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 4 Not reported 54 46 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$2.5M
0.020%
Dollar movement
+$2.5M
vs. prior 12 months
Last 12mo awards
4 awards
4 actions
Historical and award details for D & R PHARMACEUTICAL SERVICES, LLC
- Obligations: prior → latest
- $0 → $2.5M
- Not comparable
- Share: prior → latest
- 0% → 0.020%
- 0.0 percentage points
- All-period obligations
- $2.5M
- 0% of all-period positive obligations · 5 awards
- Recorded activity
- Since Sep 13, 2024
- through Dec 30, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 0 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$2.3M
0.020%
Dollar movement
+$2.3M
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for GUARDIAN PHARMACY OF TENNESSEE ONE, LLC
- Obligations: prior → latest
- $0 → $2.3M
- Not comparable
- Share: prior → latest
- 0% → 0.020%
- 0.0 percentage points
- All-period obligations
- $2.3M
- 0% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 23, 2026
- through Sep 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 0 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$2.0M
0.020%
Dollar movement
−$1.6M
vs. prior 12 months
Last 12mo awards
12 awards
20 actions
Historical and award details for BRACCO DIAGNOSTICS INC.
- Obligations: prior → latest
- $3.6M → $2.0M
- −45.5%
- Share: prior → latest
- 0.030% → 0.020%
- 0.0 percentage points
- All-period obligations
- $14.5M
- 0.030% of all-period positive obligations · 33 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 3 Not reported 9 7 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$1.4B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 12.7% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $769.3M overall.
- Award net obligations
- $1.4B
- Share of 12-month positive obligations
- 12.7%
Supporting data
- Prime contractor
- #1 · 97.8% share
- $769.3M net decline despite this positive action
- Funding office
- #1 · 97.9% attributed share
- $768.6M net decline despite this positive action
This action
+$1.4B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 12.6% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $769.3M overall.
- Award net obligations
- $1.4B
- Share of 12-month positive obligations
- 12.6%
Supporting data
- Prime contractor
- #1 · 97.8% share
- $769.3M net decline despite this positive action
- Funding office
- #1 · 97.9% attributed share
- $768.6M net decline despite this positive action
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 10.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $769.3M overall.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 10.8%
Supporting data
- Prime contractor
- #1 · 97.8% share
- $769.3M net decline despite this positive action
- Funding office
- #1 · 97.9% attributed share
- $768.6M net decline despite this positive action
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 10.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $769.3M overall.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 10.8%
Supporting data
- Prime contractor
- #1 · 97.8% share
- $769.3M net decline despite this positive action
- Funding office
- #1 · 97.9% attributed share
- $768.6M net decline despite this positive action
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 10.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $769.3M overall.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 10.8%
Supporting data
- Prime contractor
- #1 · 97.8% share
- $769.3M net decline despite this positive action
- Funding office
- #1 · 97.9% attributed share
- $768.6M net decline despite this positive action
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 10.6% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $769.3M overall.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 10.6%
Supporting data
- Prime contractor
- #1 · 97.8% share
- $769.3M net decline despite this positive action
- Funding office
- #1 · 97.9% attributed share
- $768.6M net decline despite this positive action
View recent award activity by date (10)
- Action+$418KAward net obligations$1.8M
- Action−$183KAward net obligations$338K
- Action+$32KAward net obligations$32K
- Action+$28KAward net obligations$28K
- Action+$23KAward net obligations$23K
- Action+$16KAward net obligations$16K
- Action+$12KAward net obligations$12K
- Action+$255KAward net obligations$255K
- Action−$233KAward net obligations$1.2M
- Action+$171KAward net obligations$1.2M
VA pharmaceutical preparation manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top VA pharmaceutical preparation manufacturing contractors?
In the 12 months through October 4, 2026, MCKESSON CORPORATION, EXELAN PHARMACEUTICALS INC, and PROGENICS PHARMACEUTICALS INC were the leading VA pharmaceutical preparation manufacturing prime contractors by positive obligations.
- #1
$10,817,431,490 in positive obligations
- #2
$95,652,698 in positive obligations
- #3
$29,155,703 in positive obligations
Rankings use reported USAspending award data.
Did VA contract obligations decrease in the pharmaceutical preparation manufacturing market?
Yes. Measured by net prime contract obligations, reported VA activity in the pharmaceutical preparation manufacturing market decreased 6.4% from $11,793,645,968 in the preceding 12 months to $11,038,022,949 in the 12 months through October 4, 2026.
- Latest 12 months
- $11,038,022,949
- Net prime contract obligations
- Preceding 12 months
- $11,793,645,968
- Net prime contract obligations
- Change
- −6.4%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent VA contract award activity was reported in the pharmaceutical preparation manufacturing market?
Recent VA contract award activity reported in the pharmaceutical preparation manufacturing market included actions for MCKESSON CORPORATION during the 12 months through October 4, 2026.
-
MCKESSON CORPORATION · PIID 36C24026K1002
Base award · November 1, 2025 · Action obligation: +$1,406,868,182
-
MCKESSON CORPORATION · PIID 36C24026K1008
Base award · May 1, 2026 · Action obligation: +$1,398,025,092
-
MCKESSON CORPORATION · PIID 36C24026K1010
Base award · July 1, 2026 · Action obligation: +$1,194,619,137
-
MCKESSON CORPORATION · PIID 36C24026K1009
Base award · June 1, 2026 · Action obligation: +$1,191,973,258
-
MCKESSON CORPORATION · PIID 36C24026K1007
Base award · April 1, 2026 · Action obligation: +$1,191,348,081
-
MCKESSON CORPORATION · PIID 36C24026K1006
Base award · March 1, 2026 · Action obligation: +$1,175,683,451
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for VA contracts under NAICS 325412?
From October 5, 2025 through October 4, 2026, VA reported 968 positive-obligation awards for pharmaceutical preparation manufacturing under NAICS 325412. The leading award type was delivery order. The leading reported procedure was negotiated proposal/quote.
- Positive-obligation awards
- 968
- Leading reported procedure
- Negotiated Proposal/Quote
- 86.8% of positive obligations
- Leading award type
- Delivery Order
- 99.2% of positive obligations
- Full and open
- 88.1%
- of positive obligations
- Reported parent IDV
- 99.6%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through October 4, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology